Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Ciarlet

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Vaccine|September 3, 2013
Global distribution of group A rotavirus strains in horses: a systematic reviewHajnalka Papp, Jelle Matthijnssens, Vito Martella, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccineMichelle G Goveia, Max Ciarlet, Katey E Owen, et al.
Journal of Virology|December 12, 2001
Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infectionMax Ciarlet, Margaret E Conner, Milton J Finegold, et al.
Veterinary Microbiology|October 15, 2010
Molecular characterization of equine rotaviruses circulating in Argentinean foals during a 17-year surveillance period (1992-2008)Lorena Garaicoechea, Samuel Miño, Max Ciarlet, et al.
The Journal of General Virology|March 9, 2018
Complete genome characterization of a rotavirus B (RVB) strain identified in Alpine goat kids with enteritis reveals inter-species transmission with RVB bovine strainsFangzhou Chen, Todd P Knutson, Max Ciarlet, et al.
The Pediatric Infectious Disease Journal|May 6, 2010
Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccineTimo Vesikari, Aino Karvonen, Shannon Allen Ferrante, et al.
Viruses|November 24, 2022
Evolution of Animal South American RVA Told by the NSP4 Gene E12 GenotypeSamuel Orlando Miño, Alejandra Badaracco, Enrique Louge Uriarte, et al.
Vaccine|June 11, 2019
A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infantsRaches Ella, Sudhir Babji, Max Ciarlet, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjectsJody Lawrence, Su He, Jason Martin, et al.
Expert Review of Vaccines|December 20, 2012
Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?Jelle Matthijnssens, Osamu Nakagomi, Carl D Kirkwood, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Vaccine|September 3, 2013
Global distribution of group A rotavirus strains in horses: a systematic reviewHajnalka Papp, Jelle Matthijnssens, Vito Martella, et al.
Annals of the New York Academy of Sciences|March 26, 2011
Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccineMichelle G Goveia, Max Ciarlet, Katey E Owen, et al.
Journal of Virology|December 12, 2001
Group A rotavirus infection and age-dependent diarrheal disease in rats: a new animal model to study the pathophysiology of rotavirus infectionMax Ciarlet, Margaret E Conner, Milton J Finegold, et al.
Veterinary Microbiology|October 15, 2010
Molecular characterization of equine rotaviruses circulating in Argentinean foals during a 17-year surveillance period (1992-2008)Lorena Garaicoechea, Samuel Miño, Max Ciarlet, et al.
The Journal of General Virology|March 9, 2018
Complete genome characterization of a rotavirus B (RVB) strain identified in Alpine goat kids with enteritis reveals inter-species transmission with RVB bovine strainsFangzhou Chen, Todd P Knutson, Max Ciarlet, et al.
The Pediatric Infectious Disease Journal|May 6, 2010
Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccineTimo Vesikari, Aino Karvonen, Shannon Allen Ferrante, et al.
Viruses|November 24, 2022
Evolution of Animal South American RVA Told by the NSP4 Gene E12 GenotypeSamuel Orlando Miño, Alejandra Badaracco, Enrique Louge Uriarte, et al.
Vaccine|June 11, 2019
A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infantsRaches Ella, Sudhir Babji, Max Ciarlet, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Safety and immunogenicity of pentavalent rotavirus vaccine in a randomized, double-blind, placebo-controlled study in healthy elderly subjectsJody Lawrence, Su He, Jason Martin, et al.
Expert Review of Vaccines|December 20, 2012
Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?Jelle Matthijnssens, Osamu Nakagomi, Carl D Kirkwood, et al.
Pageof 8